NanoRepro AG
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NNGRF research report →
Companywww.nanorepro.com
NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as rapid SARS-CoV-2 antibody test and corona antigen rapid test.
- CEO
- Lisa Jungst
- IPO
- 2021
- Employees
- 17
- HQ
- Marburg, DE
Price Chart
Valuation
- Market Cap
- $164.30M
- P/E
- -12.00
- P/S
- 4.00
- P/B
- 0.55
- EV/EBITDA
- -6.19
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 43.17%
- Op Margin
- -44.77%
- Net Margin
- -33.37%
- ROE
- -4.57%
- ROIC
- -6.14%
Growth & Income
- Revenue
- $4.65M · 43.15%
- Net Income
- $-2,045,757.4 · 56.34%
- EPS
- $-0.16 · 56.76%
- Op Income
- $-3,623,835
- FCF YoY
- 192.15%
Performance & Tape
- 52W High
- $12.76
- 52W Low
- $12.76
- 50D MA
- $12.76
- 200D MA
- $12.76
- Beta
- -2.94
- Avg Volume
- 0
Get TickerSpark's AI analysis on NNGRF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our NNGRF Coverage
We haven't published any research on NNGRF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NNGRF Report →